Collegium Wins Across Multiple Venues Over 505(b)(2) Drug For Managing Pain

September 29, 2016

  • In the District of Delaware (Purdue Pharma L.P. v. Collegium Pharm., Inc., Civ. No. 15-260 (D. Del.)):
    • Successfully moved to transfer action to the District of Massachusetts.
  • In the District of Massachusetts (Purdue Pharma, L.P. v. Collegium Pharm., Inc., 15-13099-FDS (D. Mass.)):
    • Obtained a judgment of invalidity of three Orange Book-listed patents.
    • Obtained summary judgment of non-infringement of two additional patents.
  • In the Patent Trial and Appeal Board (Collegium Pharm., Inc. v. Purdue Pharma L.P., PGR2018-00048):
    • Obtained post-grant review of patent that was a continuation of a parent patent filed well before 2013.
Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer
Back to Top